TFFP
TFF Pharmaceuticals, Inc.
NASDAQHealthcareBiotechnologyUS
Company Profile
CEO
Harlan F. Weisman
IPO Date
2019-10-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
TFF Pharmaceuticals, Inc.
CEO
Harlan F. Weisman
IPO Date
2019-10-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 3,165 |
| $1.82 |
| 8 Jul 2024 | KING THOMAS BRAXTON | director | A-Award | Acquired | 1,583 | $0.00 |
| 8 Jul 2024 | KING THOMAS BRAXTON | director | A-Award | Acquired | 1,583 | $1.82 |
| 8 Jul 2024 | Weisman Harlan F | director, officer: President and CEO | A-Award | Acquired | 27,480 | $0.00 |
| 8 Jul 2024 | Weisman Harlan F | director, officer: President and CEO | A-Award | Acquired | 27,480 | $1.82 |
| 8 Jul 2024 | Roberts Brandi | director | A-Award | Acquired | 3,165 | $0.00 |
| 8 Jul 2024 | Roberts Brandi | director | A-Award | Acquired | 3,165 | $1.82 |
| 8 Jul 2024 | Lee Catherine Chai-zon | director | A-Award | Acquired | 1,583 | $0.00 |
| 8 Jul 2024 | Lee Catherine Chai-zon | director | A-Award | Acquired | 1,583 | $1.82 |